US › Healthcare

Phaos Technology Holdings (Cayman) Limited (POAS)

US · Healthcare · Medical Devices

$0.17-0.60%

Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue

$36,303

Net profit

$-3.7M

EPS

$-0.12

EPS estimate

$0.00

Net margin

-10,114.8%

Key statistics

Market cap

$5.5M

Forward P/E

0.0

P/B

0.67

Book value

$0.13

EPS (TTM)

$-0.39

52-week high

$7.39

52-week low

$0.15

50-day MA

$0.20

200-day MA

$1.83

Shareholding

Insiders

29.98%

Institutions

4.46%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Phaos Technology Holdings (Cayman) Limited — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.